Caspase-driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Apoptosis, or programmed cell death, is a crucial mechanism in cancer where tumor cells are eliminated with minimal inflammation.
• Activating caspases, key enzymes in apoptosis, is a primary target for developing novel anticancer treatments.
• Numerous natural, synthetic, and semi-synthetic compounds are being investigated for their ability to induce caspase-mediated apoptosis in cancer cells.

Purpose of the Study:

• To compile preclinical evidence on compounds that induce caspase-mediated apoptosis for cancer treatment.
• To highlight critical mechanistic pathways involved in caspase-induced apoptosis in cancer.
• To provide a comprehensive overview of therapeutic strategies targeting apoptosis in cancer therapy.

Main Methods:

• Review of preclinical data from the past two decades.
• Focus on the chemical nature and mechanistic pathways of apoptosis-inducing compounds.
• Specific attention to phytochemicals, synthetic, and semi-synthetic compounds.

Main Results:

• Discussion of over 180 compounds with potential anticancer activity via apoptosis induction.
• Identification of key components and mechanisms in caspase-mediated apoptosis.
• Compilation of evidence for natural, synthetic, and semi-synthetic agents.

Conclusions:

• Caspase-induced apoptosis is a promising strategy for targeted cancer therapy.
• A wide array of compounds, particularly phytochemicals, show potential as anticancer agents.
• Further research into these compounds can lead to the development of effective cancer treatments.